Direxion Daily Healthcare Bull 3X Shares Price & Performance (CURE)

The Direxion Daily Healthcare Bull 3X ETF (CURE) fell sharply to $77.50 on April 21, marking a 6.56% decline and extending a four-day losing streak. Increased trading volumes on falling prices and technical signals suggest more downside risk, with analysts forecasting continued weakness in the coming weeks.12

Direxion has confirmed an income dividend for CURE shareholders, with a payout of $0.34549 per share recorded on March 25 and paid on April 1. This marks the latest in a series of quarterly distributions, offering some yield to investors amid recent market turbulence for leveraged healthcare ETFs.34

CURE, the Direxion Daily Healthcare Bull 3X Shares, is experiencing heightened volatility and a broad downward trend, with recent technical indicators flashing strong sell signals. The leveraged ETF, designed for sophisticated investors, is currently viewed as high risk and is expected to remain under pressure in the near term.32